Home ›
Trademark Categories ›
Pharmaceuticals ›
2000 ›
XE ›
XENDIOR
Trademark search for:
XENDIOR
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2015-01-02 — Application filed
2015-01-06 — Application filed
2015-01-13 — Application filed
2015-03-06 — Final disposition recorded
2015-03-06 — Final disposition recorded
2015-03-06 — Assigned to examiner
2015-03-06 — Final disposition recorded
2015-08-17 — Office action issued
2015-08-17 — Correspondence received in law office
2015-08-18 — Teas/email correspondence entered
2015-08-19 — Approved for pub - principal register
2015-09-14 — Assigned to lie
2015-09-16 — Law office publication review completed
2015-09-30 — Notification of notice of publication e-mailed
2015-10-20 — Published for opposition
2015-10-20 — Official gazette publication confirmation e-mailed
2015-12-15 — Noa e-mailed - sou required from applicant
2016-06-01 — Sou teas extension received
2016-06-01 — Sou extension 1 filed
2016-06-01 — Sou extension 1 granted
2016-06-03 — Notice of approval of extension request e-mailed
2016-10-25 — Sou teas extension received
2016-10-25 — Sou extension 2 filed
2016-11-10 — Case assigned to intent to use paralegal
2016-11-12 — Sou extension 2 granted
2016-11-15 — Notice of approval of extension request e-mailed
2017-06-07 — Sou teas extension received
2017-06-07 — Sou extension 3 filed
2017-06-07 — Sou extension 3 granted
2017-06-09 — Notice of approval of extension request e-mailed
2017-11-02 — Sou teas extension received
2017-11-02 — Sou extension 4 granted
2017-11-02 — Sou extension 4 filed
2017-11-04 — Notice of approval of extension request e-mailed
2018-05-08 — Sou teas extension received
2018-05-08 — Sou extension 5 filed
2018-05-10 — Sou extension 5 granted
2018-05-11 — Notice of approval of extension request e-mailed
2019-01-21 — Application abandoned
2019-01-21 — Final status recorded
2019-01-22 — Application abandoned
Owner Information
Pfizer Inc.
New York , NY
Pfizer Inc.
New York , NY
Correspondent
KATRINA EDGE Pfizer Inc 235 E 42nd St New York, NY 10017-5703 UNITED STATES
Filing Details
Filing Date:
2015-01-02
Status Date:
2019-01-21
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.